Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated urinary tract infections ...

Simultaneously, we applied this workflow to pathogenic variants from other liver-centered diseases such as galactosemia, citrullinemia type 1, argininosuccinic acidemia, methylmalonic acidemia, and ...